FDA 483 - Par Formulations Private Limited - April 05, 2022

Par Formulations Private Limited, a drug manufacturer in Dhar, India, was inspected by the FDA from March 29 to April 5, 2022. The inspection revealed significant deficiencies in equipment cleaning, personnel gowning practices, and laboratory control mechanisms for glassware, indicating potential contamination risks for drug products intended for the US market.